Visual loss from hyphema following intravitreal bevacizumab
نویسندگان
چکیده
منابع مشابه
Visual improvement following intravitreal bevacizumab (Avastin) in exudative age-related macular degeneration.
PURPOSE To study the visual and anatomic outcome of intravitreal bevacizumab injection in the treatment of exudative age-related macular degeneration (AMD). METHODS Retrospective review of patients who received one or more intravitreal bevacizumab injections for exudative AMD. Outcome measures include standardized visual acuity, optical coherence tomography (OCT), macular thickness and volume...
متن کاملCase of endophthalmitis following intravitreal injections of bevacizumab
PURPOSE We report a case of infectious endophthalmitis that developed after the third intravitreal injection of bevacizumab. The endophthalmitis was caused by Staphylococcus epidermidis. METHODS Observational case series. RESULTS This was a case of a 77-year-old man who had received three intravitreal injections of bevacizumab and developed infectious endophthalmitis. Polymerase chain react...
متن کاملIntravitreal bevacizumab for neovascular glaucoma following central retinal artery occlusion.
PURPOSE To report a case of neovascular glaucoma due to central retinal artery occlusion treated with a single intravitreal injection of bevacizumab. METHODS A 68-year-old patient with a 10-week history of central retinal artery occlusion presented with neovascularization of the iris and the angle and intraocular pressure of 30 mm Hg. The patient received a single injection of 1.25 mg bevaciz...
متن کاملAcute anterior uveitis following intravitreal bevacizumab but not subsequent ranibizumab
PURPOSE Previous reports have identified noninfectious uveitis as a potential sequela following both intravitreal bevacizumab and ranibizumab injections. We present two unique cases of acute anterior uveitis following intravitreal bevacizumab that did not occur with subsequent ranibizumab injections. METHODS Case report. CONCLUSION These cases may reflect differences in the etiology of ante...
متن کاملPersistent elevation of intraocular pressure following intravitreal injection of bevacizumab.
BACKGROUND The number of patients treated with intravitreal injections has increased significantly over the past few years, mainly following the introduction of anti-vascular endothelial growth factor antibody intraocular drugs. Bevacizumab is mostly used in this group of medications. OBJECTIVES To describe persistent elevation of intraocular pressure (IOP) following intravitreal injection of...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Case Reports
سال: 2010
ISSN: 1757-790X
DOI: 10.1136/bcr.12.2009.2520